These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29261338)

  • 1. Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer's Disease.
    Shen P; Yue Y; Zheng J; Park Y
    Annu Rev Food Sci Technol; 2018 Mar; 9():1-22. PubMed ID: 29261338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A living model for obesity and aging research: Caenorhabditis elegans.
    Shen P; Yue Y; Park Y
    Crit Rev Food Sci Nutr; 2018 Mar; 58(5):741-754. PubMed ID: 27575804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease.
    Morcos M; Hutter H
    J Alzheimers Dis; 2009; 16(4):897-908. PubMed ID: 19387121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caenorhabditis elegans reproductive aging: Regulation and underlying mechanisms.
    Luo S; Murphy CT
    Genesis; 2011 Feb; 49(2):53-65. PubMed ID: 21105070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Caenorhabditis elegans as a model for aging and age-related diseases.
    Olsen A; Vantipalli MC; Lithgow GJ
    Ann N Y Acad Sci; 2006 May; 1067():120-8. PubMed ID: 16803977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low survivorship of dauer larva in the nematode Caenorhabditis japonica, a potential comparative system for a model organism, C. elegans.
    Tanaka R; Okumura E; Kanzaki N; Yoshiga T
    Exp Gerontol; 2012 May; 47(5):388-93. PubMed ID: 22426108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mudd N; Liceaga AM
    Curr Res Food Sci; 2022; 5():845-856. PubMed ID: 35619588
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Yue Y; Li S; Shen P; Park Y
    Curr Res Food Sci; 2021; 4():692-697. PubMed ID: 34647034
    [No Abstract]   [Full Text] [Related]  

  • 12. [A Nematode Nobel Prize: Caenorhabditis elegans].
    Savel J; Clostre F
    Ann Pharm Fr; 2006 Sep; 64(5):291-307. PubMed ID: 17095949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Caenorhabditis elegans To Study the Potential Bioactivity of Natural Compounds.
    Liao VH
    J Agric Food Chem; 2018 Feb; 66(8):1737-1742. PubMed ID: 29393643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model.
    Kumar J; Park KC; Awasthi A; Prasad B
    CNS Neurol Disord Drug Targets; 2015; 14(2):295-302. PubMed ID: 25613505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of stress in ageing: research on the nematode, Caenorhabditis elegans.
    Ishii N
    Br J Dermatol; 2005 Dec; 153 Suppl 2():1-5. PubMed ID: 16280015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Bioassay of Biologically Active Substances (BAS) with Geroprotective Properties in the Model of the Nematode Caenorhabditis Elegans in In Vivo Experiments.
    Dyshlyuk LS; Dmitrieva AI; Drozdova MY; Milentyeva IS; Prosekov AY
    Curr Aging Sci; 2022; 15(2):121-134. PubMed ID: 34856917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans life span studies: the challenge of maintaining synchronous cohorts.
    Gruber J; Poovathingal SK; Schaffer S; Ng LF; Gunawan R; Halliwell B
    Rejuvenation Res; 2010; 13(2-3):347-9. PubMed ID: 20426619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Ca
    Alvarez J; Alvarez-Illera P; García-Casas P; Fonteriz RI; Montero M
    Cells; 2020 Jan; 9(1):. PubMed ID: 31947609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.